Skip Navigation
Skip to contents

Journal of Microbiology : Journal of Microbiology

OPEN ACCESS
SEARCH
Search
Advanced Search
mobile menu button

Articles

Page Path
HOME > J. Microbiol > Volume 60(3); 2022 > Article
Review
Current status and perspectives on vaccine development against dengue virus infection
Jisang Park 1,2, Ju Kim 3, Yong-Suk Jang 1,2,3
Journal of Microbiology 2022;60(3):247-254.
DOI: https://doi.org/10.1007/s12275-022-1625-y
Published online: February 14, 2022
1Department of Bioactive Material Sciences and the Research Center of Bioactive Materials, Jeonbuk National University, Jeonju 54896, Republic of Korea, 2Innovative Research and Education Center for Integrated Bioactive Materials, Jeonbuk National University, Jeonju 54896, Republic of Korea, 3Department of Molecular Biology and the Institute for Molecular Biology and Genetics, Jeonbuk National University, Jeonju 54896, Republic of Korea
Corresponding author:  Yong-Suk Jang , Tel: +82-63-270-3343, 
Received: 1 December 2021   • Revised: 12 January 2022   • Accepted: 12 January 2022
prev next
  • 225 Views
  • 0 Download
  • 29 Web of Science
  • 32 Crossref
  • 36 Scopus
Full Article

Abstract

Dengue virus (DENV) consists of four serotypes in the family Flaviviridae and is a causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome. DENV is transmitted by mosquitoes, Aedes aegypti and A. albopictus, and is mainly observed in areas where vector mosquitoes live. The number of dengue cases reported by the World Health Organization increased more than 8-fold over the last two decades from 505,430 in 2000 to over 2.4 million in 2010 to 5.2 million in 2019. Although vaccine is the most effective
method
against DENV, only one commercialized vaccine exists, and it cannot be administered to children under 9 years of age. Currently, many researchers are working to resolve the various problems hindering the development of effective dengue vaccines; understanding of the viral antigen configuration would provide insight into the development of effective vaccines against DENV infection. In this review, the current status and perspectives on effective vaccine development for DENV are examined. In addition, a plausible direction for effective vaccine development against DENV is suggested.

  • Cite this Article
    Cite this Article
    export Copy Download
    Close
    Download Citation
    Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.
    Format:
    • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
    • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
    Include:
    • Citation for the content below
    Current status and perspectives on vaccine development against dengue virus infection
    J. Microbiol. 2022;60(3):247-254.   Published online February 14, 2022
    DOI: https://doi.org/10.1007/s12275-022-1625-y
    Close
Related articles
Journal of Microbiology : Journal of Microbiology
© The Microbiological Society of Korea.
TOP